On November 13, 2025 investors in healthcare services provider Ardent Health (NYSE: ARDT) saw the price of their shares tumble $4.75 (-33%) after the company announced its Q3 2025 financial results, widely missing consensus EPS estimates and revealing two adverse items characterized as non-recurring. https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg The developments and significant market reaction has prompted shareholder rights […]

Manasquan Bank is pleased to announce it has been honored once again by American Banker a Best Bank to Work For. The Best Companies Group (BCG) compiles the annual list. https://mma.prnewswire.com/media/2211104/ManasquanBank_Logo.jpg Manasquan Bank ranked #27 among U.S. banks recognized as “Best Banks” in 2025, in all asset size categories and #1 in New Jersey. Additionally,

(NYSE:FCX), NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Freeport-McMoRan Inc. (NYSE: FCX) between February 15, 2022 and September 24, 2025, both dates inclusive (the “Class Period”). A class action

(NASDAQ:MLTX), SAN FRANCISCO, Nov. 19, 2025 (GLOBE NEWSWIRE) — A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08500 (S.D.N.Y), has been filed after MoonLake (NASDAQ: MLTX) announced disastrous Phase 3 trial results for its only product candidate (sonelokimab, or “SLK”), its highly anticipated treatment for patients with skin disease (hidradenitis suppurativa

(NASDAQ:XELB), Net loss on a GAAP basis was $7.9 million for the current quarter and $14.7 million on a year-to-date basis, inclusive of various non-cash charges. Net loss on a non-GAAP basis was $1.3 million for the current quarter and $3.6 million for the current year-to-date. Current quarter Adjusted EBITDA for 2025 was negative $0.65

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Freeport-McMoRan Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – FCX GlobeNewswire November 19, 2025 NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action

Xcel Brands, Inc. Announces Third Quarter 2025 Financial Results GlobeNewswire November 19, 2025 Net loss on a GAAP basis was $7.9 million for the current quarter and $14.7 million on a year-to-date basis, inclusive of various non-cash charges. Net loss on a non-GAAP basis was $1.3 million for the current quarter and $3.6 million for

MLTX SHAREHOLDER NOTICE: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate — Hagens Berman GlobeNewswire November 19, 2025 SAN FRANCISCO, Nov. 19, 2025 (GLOBE NEWSWIRE) — A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08500 (S.D.N.Y), has been filed after

TORONTO, Nov. 19, 2025 (GLOBE NEWSWIRE) — Pathways to Education Canada, a national charitable organization supporting students in low-income communities to graduate from high school, is pleased to announce the appointment of Owen Charters as President and Chief Executive Officer, effective January 15th, 2026. With extensive experience in leading high-impact, youth-focused charities, Owen is uniquely

(NYSE:JHX), NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of James Hardie Industries plc (NYSE: JHX) between May 20, 2025 through August 18, 2025, both dates inclusive (the “Class Period”) of the important December 23, 2025 lead plaintiff deadline. SO